TRUNCATED EXPONENTIAL VERSUS DAMPED SINUSOIDAL WAVE-FORM SHOCKS FOR TRANSTHORACIC DEFIBRILLATION

Citation
Jc. Behr et al., TRUNCATED EXPONENTIAL VERSUS DAMPED SINUSOIDAL WAVE-FORM SHOCKS FOR TRANSTHORACIC DEFIBRILLATION, The American journal of cardiology, 78(11), 1996, pp. 1242-1245
Citations number
13
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
78
Issue
11
Year of publication
1996
Pages
1242 - 1245
Database
ISI
SICI code
0002-9149(1996)78:11<1242:TEVDSW>2.0.ZU;2-6
Abstract
Currently available transthoracic defibrillators use either a damped s inusoidal or truncated exponential (TE) waveform. Truncated exponentia l waveforms deliver a long pulse if the transthoraic impedance is high ; it has been suggested that such a long pulse may be less effective f or defibrillation. Our objective was to compare the ability of damped sinusoidal (DS) waveform shocks versus TE waveform shocks to terminate ventricular fibrillation (VF) and achieve survival from witnessed car diac arrest. We retrospectively reviewed field-recorded electrocardiog rams from 86 patients with witnessed VF, treated by prehospital person nel equipped with DS or TE waveform defibrillators. forty-four patient s received 130 shocks from TE defibrillators; 42 patients received 108 shocks from DS defibrillators. There were no significant differences in time from arrest to first shock (8.0 vs 8.1 minutes), nor were ther e any differences in the size of the communities involved. The shocks resulted in the following rhythms: organized rhythm: TE: 15 of 130 (12 %), DS: 24 of 108 (22%), p=0.10 (NS); persistent VF: TE: 85 of 130 (65 %), DS: 45 of 108 (42%), p <0.01; asystole: TE: 30 of 130 (23%), DS: 3 9 of 108 (36%), p=NS; and survival to hospital discharge: TE: 5 of 44 (11%), DS: 8 of 42 (19%), p=NS. We conclude that DS waveforms terminat ed VF more frequently than TE, but there was no significant difference in resumption of an organized rhythm or survival. A prospective compa rison of these 2 waveforms is needed. (C) 1996 by Excerpta Medica, Inc .